A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer
Clinical trial NCT02581423 · COMPLETED
Trial details
- NCT number
- NCT02581423
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-03-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.